264 related articles for article (PubMed ID: 29512447)
21. Inflammatory mechanisms in major depressive disorder.
Raedler TJ
Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
23. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?
Hansen PR
Curr Pharm Des; 2018; 24(3):281-290. PubMed ID: 29318966
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.
Golia E; Limongelli G; Natale F; Fimiani F; Maddaloni V; Pariggiano I; Bianchi R; Crisci M; D'Acierno L; Giordano R; Di Palma G; Conte M; Golino P; Russo MG; Calabrò R; Calabrò P
Curr Atheroscler Rep; 2014 Sep; 16(9):435. PubMed ID: 25037581
[TBL] [Abstract][Full Text] [Related]
25. The Role of
Bird JK; Calder PC; Eggersdorfer M
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29914111
[TBL] [Abstract][Full Text] [Related]
26. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression.
Tsai SJ
Med Hypotheses; 2007; 68(6):1296-9. PubMed ID: 17097821
[TBL] [Abstract][Full Text] [Related]
27. Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications.
Liu H; Luiten PG; Eisel UL; Dejongste MJ; Schoemaker RG
Neurosci Biobehav Rev; 2013 May; 37(4):561-72. PubMed ID: 23415700
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Strategies for Treatment of Inflammation-related Depression.
Adzic M; Brkic Z; Mitic M; Francija E; Jovicic MJ; Radulovic J; Maric NP
Curr Neuropharmacol; 2018 Jan; 16(2):176-209. PubMed ID: 28847294
[TBL] [Abstract][Full Text] [Related]
29. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
30. Cell signaling and biological pathway in cardiovascular diseases.
Chae CW; Kwon YW
Arch Pharm Res; 2019 Mar; 42(3):195-205. PubMed ID: 30877558
[TBL] [Abstract][Full Text] [Related]
31. Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide.
Dang R; Zhou X; Tang M; Xu P; Gong X; Liu Y; Jiao H; Jiang P
Eur J Nutr; 2018 Apr; 57(3):893-906. PubMed ID: 28058465
[TBL] [Abstract][Full Text] [Related]
32. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
33. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response.
Maes M; Mihaylova I; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):875-80. PubMed ID: 18063921
[TBL] [Abstract][Full Text] [Related]
34. Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?
Caruso G; Fresta CG; Grasso M; Santangelo R; Lazzarino G; Lunte SM; Caraci F
Curr Med Chem; 2020; 27(11):1782-1800. PubMed ID: 31296155
[TBL] [Abstract][Full Text] [Related]
35. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.
Hauser TH; Salastekar N; Schaefer EJ; Desai T; Goldfine HL; Fowler KM; Weber GM; Welty F; Clouse M; Shoelson SE; Goldfine AB;
JAMA Cardiol; 2016 Jul; 1(4):413-23. PubMed ID: 27438317
[TBL] [Abstract][Full Text] [Related]
36. Statins: Neurobiological underpinnings and mechanisms in mood disorders.
Walker AJ; Kim Y; Borissiouk I; Rehder R; Dodd S; Morris G; Nierenberg AA; Maes M; Fernandes BS; Dean OM; Williams LJ; Eyre HA; Kim SW; Zoungas S; Carvalho AF; Berk M
Neurosci Biobehav Rev; 2021 Sep; 128():693-708. PubMed ID: 34265321
[TBL] [Abstract][Full Text] [Related]
37. Statins, ACE inhibitors and ARBs in cardiovascular disease.
Montecucco F; Mach F
Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):389-400. PubMed ID: 19520311
[TBL] [Abstract][Full Text] [Related]
38. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
39. The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy.
Soran H; Schofield JD; Durrington PN
Curr Opin Lipidol; 2014 Aug; 25(4):239-46. PubMed ID: 24978144
[TBL] [Abstract][Full Text] [Related]
40. View of statins as antimicrobials in cardiovascular risk modification.
Kozarov E; Padro T; Badimon L
Cardiovasc Res; 2014 Jun; 102(3):362-74. PubMed ID: 24623278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
